[ Price : $8.95]
FDA releases the form FDA-483 issued following an inspection at the Little Rock, AR-based SCA Pharmaceuticals outsourcing facility...[ Price : $8.95]
Mercks Keytruda with concurrent chemoradiotherapy meets the progression-free survival primary endpoint in an interim analysis of t...[ Price : $8.95]
FDA clears an Xstrahl 510(k) for its Radiant Aura treatment device for providing radiation therapy to non-melanoma skin cancer pat...[ Price : $8.95]
FDA grants Karyopharm Therapeutics fast track status for selinexor for treating patients with myelofibrosis.[ Price : $8.95]
The CDER Office of Translational Sciences 2022 annual report lists what it says were achievements in five areas of activity.[ Price : $8.95]
Bipartisan leaders of the House Energy and Commerce Committee express concerns about FDA foreign inspections and ask for answers t...[ Price : $8.95]
Akebia Therapeutics completes an End of Dispute Type A meeting with FDA that discussed the companys upcoming NDA resubmission for ...[ Price : $8.95]
Medtronic recalls its implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators with glassed fe...